BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8561474)

  • 1. Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase.
    Bergstrom JD; Dufresne C; Bills GF; Nallin-Omstead M; Byrne K
    Annu Rev Microbiol; 1995; 49():607-39. PubMed ID: 8561474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
    Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
    J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.
    Bergstrom JD; Kurtz MM; Rew DJ; Amend AM; Karkas JD; Bostedor RG; Bansal VS; Dufresne C; VanMiddlesworth FL; Hensens OD
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):80-4. PubMed ID: 8419946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory activity to protein prenylation and antifungal activity of zaragozic acid D3, a potent inhibitor of squalene synthase produced by the fungus, Mollisia sp. SANK 10294.
    Tanimoto T; Ohya S; Tsujita Y
    J Antibiot (Tokyo); 1998 Apr; 51(4):428-31. PubMed ID: 9630865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.
    Procopiou PA; Cox B; Kirk BE; Lester MG; McCarthy AD; Sareen M; Sharratt PJ; Snowden MA; Spooner SJ; Watson NS; Widdowson J
    J Med Chem; 1996 Mar; 39(7):1413-22. PubMed ID: 8691471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activities of novel zaragozic acids, the potent inhibitors of squalene synthase, produced by the fungus, Mollisia sp. SANK 10294.
    Tanimoto T; Hamano K; Onodera K; Hosoya T; Kakusaka M; Hirayama T; Shimada Y; Koga T; Tsujita Y
    J Antibiot (Tokyo); 1997 May; 50(5):390-4. PubMed ID: 9207908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase.
    Dufresne C; Wilson KE; Singh SB; Zink DL; Bergstrom JD; Rew D; Polishook JD; Meinz M; Huang L; Silverman KC
    J Nat Prod; 1993 Nov; 56(11):1923-9. PubMed ID: 8289063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. II. Structure elucidation.
    Sidebottom PJ; Highcock RM; Lane SJ; Procopiou PA; Watson NS
    J Antibiot (Tokyo); 1992 May; 45(5):648-58. PubMed ID: 1624367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of viridiofungins.
    Onishi JC; Milligan JA; Basilio A; Bergstrom J; Curotto J; Huang L; Meinz M; Nallin-Omstead M; Pelaez F; Rew D; Salvatore M; Thompson J; Vicente F; Kurtz MB
    J Antibiot (Tokyo); 1997 Apr; 50(4):334-8. PubMed ID: 9186560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
    Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
    Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis.
    Kojro E; Füger P; Prinzen C; Kanarek AM; Rat D; Endres K; Fahrenholz F; Postina R
    J Alzheimers Dis; 2010; 20(4):1215-31. PubMed ID: 20413873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity.
    Dawson MJ; Farthing JE; Marshall PS; Middleton RF; O'Neill MJ; Shuttleworth A; Stylli C; Tait RM; Taylor PM; Wildman HG
    J Antibiot (Tokyo); 1992 May; 45(5):639-47. PubMed ID: 1624366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.
    Ness GC; Zhao Z; Lopez D
    Arch Biochem Biophys; 1996 Jan; 325(2):242-8. PubMed ID: 8561503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspergillus flavus squalene synthase as an antifungal target: Expression, activity, and inhibition.
    Song J; Shang N; Baig N; Yao J; Shin C; Kim BK; Li Q; Malwal SR; Oldfield E; Feng X; Guo RT
    Biochem Biophys Res Commun; 2019 May; 512(3):517-523. PubMed ID: 30904161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory responses to inhibition of hepatic squalene synthase.
    Lopez D; Chambers CM; Keller RK; Ness GC
    Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
    Ness GC; Zhao Z; Keller RK
    Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preparation of zaragozic acid A analogues by directed biosynthesis.
    Chen TS; Petuch B; MacConnell J; White R; Dezeny G; Arison B; Bergstrom JD; Colwell L; Huang L; Monaghan RL
    J Antibiot (Tokyo); 1994 Nov; 47(11):1290-4. PubMed ID: 8002393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol.
    Bostedor RG; Karkas JD; Arison BH; Bansal VS; Vaidya S; Germershausen JI; Kurtz MM; Bergstrom JD
    J Biol Chem; 1997 Apr; 272(14):9197-203. PubMed ID: 9083051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells.
    Petras SF; Lindsey S; Harwood HJ
    J Lipid Res; 1999 Jan; 40(1):24-38. PubMed ID: 9869647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid.
    Haeuptle MA; Welti M; Troxler H; Hülsmeier AJ; Imbach T; Hennet T
    J Biol Chem; 2011 Feb; 286(8):6085-91. PubMed ID: 21183681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.